Mutant peptides derived from SARS-CoV-2 inhibit the ability of T cells to recognize and destroy infectious cells
An in-depth study of 747 SARS-CoV-2 virus has revealed that mutant peptides derived from the virus cannot effectively bind to inflammatory proteins on the surface of infectious cells and thus inhib…
